Using Win Odds to Improve Commit‐to‐Phase‐3 Decision‐Making in Oncology
Statistics in Medicine · 2025
DOI: 10.1002/sim.70024 ↗At a glance
Journal article in Statistics in Medicine, 2025. Written by Benjamin F Hartley and 5 co-authors. Institution: Veramed Ltd., Twickenham, UK. Major MEDLINE topics: Clinical Trials, Phase III as Topic, Decision Making, Medical Oncology. Cited 2 times so far (Crossref); 43 references. Funded by: GlaxoSmithKline, GlaxoSmithKline España.
Abstract (original language)
Making good decisions about whether to commit‐to‐phase 3 clinical trials is challenging. This is especially true in oncology because the relationships between the registration endpoint, overall survival, and endpoints such as progression‐free survival and confirmed objective response are often poorly understood. We present a framework for decision‐making based on a three‐endpoint win odds. We discuss properties of the win odds and suggest that it can be interpreted, for decision‐making, as the reciprocal of an average hazard ratio for overall survival. We confirm the performance of the decision‐making method using simulation studies and a clinical trial case study. As part of this work, we describe the simulation of correlated patient‐level oncology endpoints using a multi‐state model of disease. This model can provide clinically realistic data for testing the performance of analysis methods. We conclude that the win odds can improve commit‐to‐phase‐3 decision‐making compared with other methods.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Veramed Ltd., Twickenham, UK.
- Statistics and Data Science Innovation Hub, GSK Research and Development, Brentford, UK.
- Oncology Statistics, GSK Research and Development, Collegeville, Pennsylvania, USA.
- Statistical Methodology, Bristol Myers Squibb, Princeton, New Jersey, USA.
ORCID profiles: Benjamin F Hartley, Thomas Drury, Brian Di Pace, Tai-Tsang Chen, Inna Perevozskaya
Funding
- GlaxoSmithKline
- GlaxoSmithKline España
Cite
APA
Hartley, B. F., Drury, T., Di Pace, B., Zhou, H., Chen, T. T., & Perevozskaya, I. (2025). Using Win Odds to Improve Commit‐to‐Phase‐3 Decision‐Making in Oncology. Statistics in Medicine. https://doi.org/10.1002/sim.70024
Vancouver
Hartley BF, Drury T, Di Pace B, Zhou H, Chen TT, Perevozskaya I. Using Win Odds to Improve Commit‐to‐Phase‐3 Decision‐Making in Oncology. Statistics in Medicine. 2025. doi:10.1002/sim.70024
BibTeX
@article{Hartley2025,
author = {Hartley, Benjamin F and Drury, Thomas and Di Pace, Brian and Zhou, Helen and Chen, Tai-Tsang and Perevozskaya, Inna},
title = {Using Win Odds to Improve Commit‐to‐Phase‐3 Decision‐Making in Oncology},
journal = {Statistics in Medicine},
year = {2025},
doi = {10.1002/sim.70024}
}
EUVIMED